This inventor holds 2 USPTO granted patents. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 1979-1982.
Company Filing History:
Years Active: 1979-1982
Title: John B Hobbs: Innovator in Viral Infection Treatment
Introduction
John B Hobbs is a notable inventor based in Göttingen, Germany. He has made significant contributions to the field of virology through his innovative research and patented inventions. With a total of 2 patents, Hobbs has focused on developing methods for treating viral infections.
Latest Patents
Hobbs' latest patents include groundbreaking work on compositions for inhibiting cell growth, particularly in the treatment of viral infections. One of his notable inventions is a method that utilizes the nucleoside 2'-azido-2'-desoxycytidine. Additionally, he has developed a process for producing 2'-substituted-D-ribofuranosyl purine compounds, which includes 2'-azido-D-ribofuranosyl purine compounds.
Career Highlights
Hobbs is affiliated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V., where he continues to advance his research. His work has been instrumental in the development of new therapeutic strategies against viral diseases.
Collaborations
Some of his notable coworkers include Fritz Eckstein and Lambert Skoog, who have collaborated with him on various research projects.
Conclusion
John B Hobbs is a distinguished inventor whose work in viral infection treatment has the potential to impact public health significantly. His innovative patents reflect his commitment to advancing medical science and improving treatment options for viral infections.